Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)

NCT06155279 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Pleural Mesothelioma

Interventions

DRUG: Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab

Sponsor

Istituto Oncologico Veneto IRCCS

Collaborators

[object Object]